Unum Therapeutics Inc. | 200 Cambridge Park Drive Suite 3100 | Cambridge, MA 02140  USA

Tel. +1.617.945.5576 | Email: info@unumrx.com

  • LinkedIn - White Circle
  • Twitter - White Circle

© Copyright 2014-2019 Unum Therapeutics

August 8, 2016


Unum Therapeutics to Present at 2016 Wedbush PacGrow Healthcare Conference


CAMBRIDGE, MA, August 8, 2016 Unum Therapeutics, a clinical stage biopharmaceutical company developing a universal cellular immunotherapy to treat multiple cancers, today announced that President and Chief Executive Officer Chuck Wilson will present at the Wedbush PacGrow Healthcare Conference on August 17, 2016 at 1:20 pm ET. The conference is being held August 16-17, 2016 at the Le Parker Meridien in New York.


Unum Therapeutics


Unum uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body’s own immune system to fight cancer. The Company’s lead program, which combines Unum’s proprietary Antibody-Coupled T-cell Receptor (ACTR) technology with rituximab, is in Phase 1 clinical testing to assess its safety and efficacy. The company is headquartered in Cambridge, MA. For more information, visit www.unumrx.com.



Media Contact:

Mike Beyer

Sam Brown Inc.

+ 1.312.961.2502